{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:58:12Z","timestamp":1780369092014,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS89757"],"award-info":[{"award-number":["R01-NS89757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016608","name":"Rainwater Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10286-023-00946-w","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T11:45:40Z","timestamp":1684151140000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer in pathologically confirmed multiple system atrophy"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6364-5362","authenticated-orcid":false,"given":"William P.","family":"Cheshire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Uitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"issue":"6","key":"946_CR1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L et al. (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37(6):1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"issue":"6","key":"946_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","volume":"33","author":"JQ Trojanowski","year":"2007","unstructured":"Trojanowski JQ, Revesz T, Neuropathology Working Group on MSA (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33(6):615\u201320. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00907.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"946_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/s0002-9440(10)65226-1","volume":"155","author":"DW Dickson","year":"1999","unstructured":"Dickson DW, Liu W, Hardy J et al. (1999) Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 155(4):1241\u20131251. https:\/\/doi.org\/10.1016\/s0002-9440(10)65226-1","journal-title":"Am J Pathol"},{"issue":"14","key":"946_CR4","doi-asserted-by":"publisher","first-page":"11970","DOI":"10.1074\/jbc.M109541200","volume":"277","author":"VN Uversky","year":"2002","unstructured":"Uversky VN, Li J, Souillac P et al. (2002) Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem 277(14):11970\u201311978. https:\/\/doi.org\/10.1074\/jbc.M109541200","journal-title":"J Biol Chem"},{"issue":"1","key":"946_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41531-021-00179-6","volume":"7","author":"KM Miller","year":"2021","unstructured":"Miller KM, Mercado NM, Sortwell CE (2021) Synucleinopathy-associated pathogenesis in Parkinson\u2019s disease and the potential for brain-derived neurotrophic factor [published online April 12, 2001]. NPJ Parkinson\u2019s Dis 7(1):35. https:\/\/doi.org\/10.1038\/s41531-021-00179-6","journal-title":"NPJ Parkinson\u2019s Dis"},{"issue":"5","key":"946_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","volume":"6","author":"WS Kim","year":"2014","unstructured":"Kim WS, K\u00e5gedal K, Halliday GM (2014) Alpha-synuclein biology in Lewy body diseases [published online October 27, 2014]. Alzheimers Res Ther 6(5):73. https:\/\/doi.org\/10.1186\/s13195-014-0073-2","journal-title":"Alzheimers Res Ther"},{"key":"946_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29337","author":"PE Sugier","year":"2023","unstructured":"Sugier PE, Lucotte EA, Domenighetti C et al. (2023) Comprehensive unbiased risk factor assessment for genetics and environment in Parkinson\u2019s disease (Courage-PD) consortium; Truong T ,Elbaz A. Investigation of shared genetic risk factors between Parkinson\u2019s disease and cancers. Mov Disord. https:\/\/doi.org\/10.1002\/mds.29337","journal-title":"Mov Disord"},{"issue":"7","key":"946_CR8","doi-asserted-by":"publisher","first-page":"e046329","DOI":"10.1136\/bmjopen-2020-046329","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Guarin D, Mohammadzadehhonarvar N, Chen X, Gao X (2021) Parkinson\u2019s disease and cancer: a systematic review and meta-analysis of over 17 million participants. BMJ Open 11(7):e046329. https:\/\/doi.org\/10.1136\/bmjopen-2020-046329. (Erratum in: BMJ Open. 2021 Sep 22;11(9):e046329corr1)","journal-title":"BMJ Open"},{"key":"946_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fneur.2020.00898","volume":"11","author":"P Mencke","year":"2020","unstructured":"Mencke P, Hanss Z, Boussaad I et al. (2020) Bidirectional relation between Parkinson\u2019s disease and glioblastoma multiforme. Front Neurol 11:898. https:\/\/doi.org\/10.3389\/fneur.2020.00898","journal-title":"Front Neurol"},{"issue":"2","key":"946_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/mds.28425","volume":"36","author":"PS Filippou","year":"2021","unstructured":"Filippou PS, Outeiro TF (2021) Cancer and Parkinson\u2019s disease: common targets, emerging hopes. Mov Disord 36(2):340\u2013346. https:\/\/doi.org\/10.1002\/mds.28425","journal-title":"Mov Disord"},{"issue":"12","key":"946_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00702-005-0380-7","volume":"112","author":"N Vanacore","year":"2005","unstructured":"Vanacore N (2005) Epidemiological evidence on multiple system atrophy. J Neural Transm (Vienna) 112(12):1605\u20131612. https:\/\/doi.org\/10.1007\/s00702-005-0380-7","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"946_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00702-007-0746-0","volume":"114","author":"U W\u00fcllner","year":"2007","unstructured":"W\u00fcllner U, Schmitz-H\u00fcbsch T, Abele M, Antony G, Bauer P, Eggert K (2007) Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German competence network on Parkinson\u2019s disease. J Neural Transm (Vienna) 114(9):1161\u20131165. https:\/\/doi.org\/10.1007\/s00702-007-0746-0","journal-title":"J Neural Transm (Vienna)"},{"issue":"12","key":"946_CR13","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/mds.23185","volume":"25","author":"JH Seo","year":"2010","unstructured":"Seo JH, Yong SW, Song SK, Lee JE, Sohn YH, Lee PH (2010) A case-control study of multiple system atrophy in Korean patients. Mov Disord 25(12):1953\u20131959. https:\/\/doi.org\/10.1002\/mds.23185","journal-title":"Mov Disord"},{"issue":"15","key":"946_CR14","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/mds.23192","volume":"25","author":"M K\u00f6llensperger","year":"2010","unstructured":"K\u00f6llensperger M, Geser F, Ndayisaba JP, EMSA-SG et al. (2010) Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 25(15):2604\u20132612. https:\/\/doi.org\/10.1002\/mds.23192","journal-title":"Mov Disord"},{"issue":"3\u20134","key":"946_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000353995","volume":"71","author":"I Nozaki","year":"2014","unstructured":"Nozaki I, Kato-Motozaki Y, Ikeda T et al. (2014) Clinical features in association with neurodegenerative diseases and malignancies. Eur Neurol 71(3\u20134):99\u2013105. https:\/\/doi.org\/10.1159\/000353995","journal-title":"Eur Neurol"},{"key":"946_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1937-6448(08)01406-8","volume":"270","author":"A Surguchov","year":"2008","unstructured":"Surguchov A (2008) Molecular and cellular biology of synucleins. Int Rev Cell Mol Biol 270:225\u2013317. https:\/\/doi.org\/10.1016\/S1937-6448(08)01406-8","journal-title":"Int Rev Cell Mol Biol"},{"issue":"2","key":"946_CR17","doi-asserted-by":"publisher","first-page":"110675","DOI":"10.1016\/j.celrep.2022.110675","volume":"39","author":"KE Carnazza","year":"2022","unstructured":"Carnazza KE, Komer LE, Xie YX et al. (2022) Synaptic vesicle binding of \u03b1-synuclein is modulated by \u03b2- and \u03b3-synucleins. Cell Rep 39(2):110675. https:\/\/doi.org\/10.1016\/j.celrep.2022.110675","journal-title":"Cell Rep"},{"key":"946_CR18","doi-asserted-by":"publisher","first-page":"1010064","DOI":"10.3389\/fnagi.2022.1010064","volume":"14","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Cai H, Zhao J, Yu Z, Feng T (2022) Alpha-synuclein species in oral mucosa as potential biomarkers for multiple system atrophy. Front Aging Neurosci 14:1010064. https:\/\/doi.org\/10.3389\/fnagi.2022.1010064","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"946_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3988\/jcn.2019.15.2.135","volume":"15","author":"JY Kim","year":"2019","unstructured":"Kim JY, Illigens BM, McCormick MP, Wang N, Gibbons CH (2019) Alpha-synuclein in skin nerve fibers as a biomarker for alpha-synucleinopathies. J Clin Neurol 15(2):135\u2013142. https:\/\/doi.org\/10.3988\/jcn.2019.15.2.135","journal-title":"J Clin Neurol"},{"issue":"2","key":"946_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s004010050406","volume":"91","author":"T Kanda","year":"1996","unstructured":"Kanda T, Tsukagoshi H, Oda M, Miyamoto K, Tanabe H (1996) Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson\u2019s disease and multiple system atrophy. Acta Neuropathol 91(2):145\u2013154. https:\/\/doi.org\/10.1007\/s004010050406","journal-title":"Acta Neuropathol"},{"key":"946_CR21","doi-asserted-by":"publisher","first-page":"135964","DOI":"10.1016\/j.neulet.2021.135964","volume":"756","author":"Z Rong","year":"2021","unstructured":"Rong Z, Shen F, Wang Y et al. (2021) Phosphorylated \u03b1-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson\u2019s disease from multiple system atrophy and progressive supranuclear paralysis [published online May 19, 2021]. Neurosci Lett 756:135964. https:\/\/doi.org\/10.1016\/j.neulet.2021.135964","journal-title":"Neurosci Lett"},{"issue":"4","key":"946_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/mds.28941","volume":"37","author":"L Barba","year":"2022","unstructured":"Barba L, Paolini Paoletti F, Bellomo G et al. (2022) Alpha and beta synucleins: from pathophysiology to clinical application as biomarkers. Mov Disord 37(4):669\u2013683. https:\/\/doi.org\/10.1002\/mds.28941","journal-title":"Mov Disord"},{"issue":"1","key":"946_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/biom12010142","volume":"12","author":"J Hayashi","year":"2022","unstructured":"Hayashi J, Carver JA (2022) \u03b2-synuclein: an enigmatic protein with diverse functionality [published online January 16, 2022]. Biomolecules 12(1):142. https:\/\/doi.org\/10.3390\/biom12010142","journal-title":"Biomolecules"},{"issue":"4","key":"946_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/cm.1035","volume":"49","author":"A Surguchov","year":"2001","unstructured":"Surguchov A, Palazzo RE, Surgucheva I (2001) Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motil Cytoskelet 49(4):218\u2013228. https:\/\/doi.org\/10.1002\/cm.1035","journal-title":"Cell Motil Cytoskelet"},{"issue":"1","key":"946_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1871524918666181012160439","volume":"19","author":"A Sanjeev","year":"2019","unstructured":"Sanjeev A, Mattaparthi VSK (2019) Computational study on the role of \u03b3-synuclein in inhibiting the \u03b1-synuclein aggregation. Cent Nerv Syst Agents Med Chem 19(1):24\u201330. https:\/\/doi.org\/10.2174\/1871524918666181012160439","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"23","key":"946_CR26","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1021\/bi300478w","volume":"51","author":"I Surgucheva","year":"2012","unstructured":"Surgucheva I, Sharov VS, Surguchov A (2012) \u03b3-Synuclein: seeding of \u03b1-synuclein aggregation and transmission between cells. Biochemistry 51(23):4743\u20134754. https:\/\/doi.org\/10.1021\/bi300478w","journal-title":"Biochemistry"},{"issue":"5","key":"946_CR27","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3892\/etm.2015.2323","volume":"9","author":"K He","year":"2015","unstructured":"He K, Wang P (2015) Unregulated long non-coding RNA-AK058003 promotes the proliferation, invasion and metastasis of breast cancer by regulating the expression levels of the \u03b3-synuclein gene. Exp Ther Med 9(5):1727\u20131732. https:\/\/doi.org\/10.3892\/etm.2015.2323","journal-title":"Exp Ther Med"},{"issue":"44","key":"946_CR28","doi-asserted-by":"publisher","first-page":"27435","DOI":"10.18632\/oncotarget.25415","volume":"9","author":"L Tian","year":"2018","unstructured":"Tian L, Zhao Y, Truong MJ, Lagadec C, Bourette RP (2018) Synuclein gamma expression enhances radiation resistance of breast cancer cells. Oncotarget 9(44):27435\u201327447. https:\/\/doi.org\/10.18632\/oncotarget.25415","journal-title":"Oncotarget"},{"issue":"4","key":"946_CR29","first-page":"759","volume":"57","author":"H Ji","year":"1997","unstructured":"Ji H, Liu YE, Jia T et al. (1997) Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57(4):759\u2013764","journal-title":"Cancer Res"},{"issue":"6","key":"946_CR30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/ijc.22763","volume":"121","author":"J Guo","year":"2007","unstructured":"Guo J, Shou C, Meng L et al. (2007) Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer 121(6):1296\u20131305. https:\/\/doi.org\/10.1002\/ijc.22763","journal-title":"Int J Cancer"},{"issue":"3","key":"946_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12032-013-0612-x","volume":"30","author":"K Wu","year":"2013","unstructured":"Wu K, Huang S, Zhu M et al. (2013) Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer [published online May 22, 2013]. Med Oncol 30(3):612. https:\/\/doi.org\/10.1007\/s12032-013-0612-x","journal-title":"Med Oncol"},{"key":"946_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12935-020-01401-w","volume":"20","author":"CC Hsu","year":"2020","unstructured":"Hsu CC, Su YF, Tsai KY et al. (2020) Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy [published online July 10, 2020]. Cancer Cell Int 20:300. https:\/\/doi.org\/10.1186\/s12935-020-01401-w. (Erratum in: Cancer Cell Int 2020 Aug 26;20:410)","journal-title":"Cancer Cell Int"},{"issue":"2","key":"946_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3892\/mmr.2020.11777","volume":"23","author":"J Fei","year":"2021","unstructured":"Fei J, Xiao C, Yang M, Zhou X, Gong P (2021) Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose [published online December 14, 2020]. Mol Med Rep 23(2):138. https:\/\/doi.org\/10.3892\/mmr.2020.11777","journal-title":"Mol Med Rep"},{"issue":"3","key":"946_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4149\/neo_2020_190619N523","volume":"67","author":"K Wang","year":"2020","unstructured":"Wang K, Shen Y, Xu J et al. (2020) Evaluation of synuclein-\u03b3 levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients. Neoplasma 67(3):707\u2013713. https:\/\/doi.org\/10.4149\/neo_2020_190619N523","journal-title":"Neoplasma"},{"issue":"9","key":"946_CR35","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9","volume":"88","author":"W Bruening","year":"2000","unstructured":"Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK (2000) Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88(9):2154\u20132163","journal-title":"Cancer"},{"issue":"17","key":"946_CR36","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1158\/1078-0432.CCR-08-2491","volume":"15","author":"H Hu","year":"2009","unstructured":"Hu H, Sun L, Guo C et al. (2009) Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res 15(17):5485\u20135493. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2491","journal-title":"Clin Cancer Res"},{"issue":"8","key":"946_CR37","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1158\/1078-0432.CCR-08-2946","volume":"15","author":"T Hibi","year":"2009","unstructured":"Hibi T, Mori T, Fukuma M et al. (2009) Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer [published online April 7, 2009]. Clin Cancer Res 15(8):2864\u20132871. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2946","journal-title":"Clin Cancer Res"},{"issue":"18","key":"946_CR38","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.3390\/ijms221810093","volume":"22","author":"KA Jellinger","year":"2021","unstructured":"Jellinger KA, Wenning GK, Stefanova N (2021) Is multiple system atrophy a prion-like disorder? [Published online September 18, 2021]. Int J Mol Sci 22(18):10093. https:\/\/doi.org\/10.3390\/ijms221810093","journal-title":"Int J Mol Sci"},{"issue":"9","key":"946_CR39","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/brain\/awz189","volume":"142","author":"Y Miki","year":"2019","unstructured":"Miki Y, Foti SC, Asi YT et al. (2019) Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain 142(9):2813\u20132827. https:\/\/doi.org\/10.1093\/brain\/awz189","journal-title":"Brain"},{"issue":"5","key":"946_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","volume":"85","author":"S Koga","year":"2015","unstructured":"Koga S, Aoki N, Uitti RJ et al. (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85(5):404\u2013412. https:\/\/doi.org\/10.1212\/WNL.0000000000001807","journal-title":"Neurology"},{"key":"946_CR41","unstructured":"American Cancer Society. Lifetime risk of developing and dying from cancer, 2016\u20132018. https:\/\/www.cancer.org\/content\/dam\/CRC\/PDF\/Public\/509.00.pdf. Accessed 28 Feb 2023"},{"key":"946_CR42","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. https:\/\/seer.cancer.gov. Accessed 28 Feb 2023"},{"issue":"12","key":"946_CR43","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"issue":"4","key":"946_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"issue":"1","key":"946_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, National Institute on Aging; Alzheimer\u2019s Association et al. (2012) National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123(1):1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"946_CR46","doi-asserted-by":"publisher","first-page":"1136779","DOI":"10.3389\/fphar.2023.1136779","volume":"14","author":"A Dogra","year":"2023","unstructured":"Dogra A, Kumar J (2023) Biosynthesis of anticancer phytochemical compounds and their chemistry. Front Pharmacol 14:1136779. https:\/\/doi.org\/10.3389\/fphar.2023.1136779","journal-title":"Front Pharmacol"},{"issue":"3","key":"946_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3892\/or.2020.7473","volume":"43","author":"N Al-Yousef","year":"2020","unstructured":"Al-Yousef N, Shinwari Z, Al-Shahrani B, Al-Showimi M, Al-Moghrabi N (2020) Curcumin induces re expression of BRCA1 and suppression of \u03b3 synuclein by modulating DNA promoter methylation in breast cancer cell lines. Oncol Rep 43(3):827\u2013838. https:\/\/doi.org\/10.3892\/or.2020.7473","journal-title":"Oncol Rep"},{"issue":"34","key":"946_CR48","doi-asserted-by":"publisher","first-page":"30281","DOI":"10.1021\/acsomega.2c03534","volume":"7","author":"B Xu","year":"2022","unstructured":"Xu B, Chen J, Liu Y (2022) Curcumin interacts with \u03b1-synuclein condensates to inhibit amyloid aggregation under phase separation. ACS Omega 7(34):30281\u201330290. https:\/\/doi.org\/10.1021\/acsomega.2c03534","journal-title":"ACS Omega"},{"issue":"10","key":"946_CR49","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/10715760500233113","volume":"39","author":"V Zbarsky","year":"2005","unstructured":"Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease. Free Radic Res 39(10):1119\u201325. https:\/\/doi.org\/10.1080\/10715760500233113","journal-title":"Free Radic Res"},{"issue":"19","key":"946_CR50","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.3390\/ijms21197329","volume":"21","author":"E El Nebrisi","year":"2020","unstructured":"El Nebrisi E, Javed H, Ojha SK, Oz M, Shehab S (2020) Neuroprotective effect of curcumin on the nigrostriatal pathway in a 6-hydroxydopmine-induced rat model of Parkinson\u2019s disease is mediated by \u03b17-nicotinic receptors. Int J Mol Sci 21(19):7329. https:\/\/doi.org\/10.3390\/ijms21197329","journal-title":"Int J Mol Sci"},{"issue":"20","key":"946_CR51","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.3390\/ijms222011248","volume":"22","author":"EE Nebrisi","year":"2021","unstructured":"Nebrisi EE (2021) Neuroprotective activities of curcumin in Parkinson\u2019s disease: a review of the literature. Int J Mol Sci 22(20):11248. https:\/\/doi.org\/10.3390\/ijms222011248","journal-title":"Int J Mol Sci"},{"issue":"23","key":"946_CR52","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/hmg\/ddab188","volume":"30","author":"TE Kim","year":"2021","unstructured":"Kim TE, Newman AJ, Imberdis T et al. (2021) Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity. Hum Mol Genet 30(23):2332\u20132346. https:\/\/doi.org\/10.1093\/hmg\/ddab188","journal-title":"Hum Mol Genet"},{"issue":"23","key":"946_CR53","doi-asserted-by":"publisher","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","volume":"96","author":"JE Galvin","year":"1999","unstructured":"Galvin JE, Uryu K, Lee VM, Trojanowski JQ (1999) Axon pathology in Parkinson\u2019s disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci USA 96(23):13450\u201313455. https:\/\/doi.org\/10.1073\/pnas.96.23.13450","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"946_CR54","doi-asserted-by":"publisher","first-page":"110675","DOI":"10.1016\/j.celrep.2022.110675","volume":"39","author":"KE Carnazza","year":"2022","unstructured":"Carnazza KE, Komer LE, Xie YX, Pineda A, Briano JA, Gao V, Na Y, Ramlall T, Buchman VL, Eliezer D, Sharma M, Burr\u00e9 J (2022) Synaptic vesicle binding of \u03b1-synuclein is modulated by \u03b2- and \u03b3-synucleins. Cell Rep 39(2):110675. https:\/\/doi.org\/10.1016\/j.celrep.2022.110675","journal-title":"Cell Rep"},{"key":"946_CR55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-014-0132-8","volume":"2","author":"I Surgucheva","year":"2014","unstructured":"Surgucheva I, Newell KL, Burns J, Surguchov A (2014) New \u03b1- and \u03b3-synuclein immunopathological lesions in human brain [published online September 11, 2014]. Acta Neuropathol Commun 2:132. https:\/\/doi.org\/10.1186\/s40478-014-0132-8","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"946_CR56","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1006\/exnr.1999.7228","volume":"160","author":"JE Duda","year":"1999","unstructured":"Duda JE, Shah U, Arnold SE, Lee VM, Trojanowski JQ (1999) The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 160(2):515\u2013522. https:\/\/doi.org\/10.1006\/exnr.1999.7228","journal-title":"Exp Neurol"},{"issue":"8","key":"946_CR57","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/archneurol.2010.177","volume":"67","author":"K Nishioka","year":"2010","unstructured":"Nishioka K, Wider C, Vilari\u00f1o-G\u00fcell C et al. (2010) Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease. Arch Neurol 67(8):970\u20135. https:\/\/doi.org\/10.1001\/archneurol.2010.177","journal-title":"Arch Neurol"},{"issue":"10","key":"946_CR58","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/hmg\/ddp090","volume":"18","author":"N Ninkina","year":"2009","unstructured":"Ninkina N, Peters O, Millership S, Salem H, van der Putten H, Buchman VL (2009) Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein. Hum Mol Genet 18(10):1779\u20131794. https:\/\/doi.org\/10.1093\/hmg\/ddp090","journal-title":"Hum Mol Genet"},{"issue":"1","key":"946_CR59","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s12885-016-2750-y","volume":"16","author":"L Min","year":"2016","unstructured":"Min L, Zhang C, Ma R, Li X, Yuan H, Li Y, Chen R, Liu C, Guo J, Qu L, Shou C (2016) Overexpression of synuclein-\u03b3 predicts lack of benefit from radiotherapy for breast cancer patients. BMC Cancer 16(1):717","journal-title":"BMC Cancer"},{"issue":"37","key":"946_CR60","doi-asserted-by":"publisher","first-page":"e4874","DOI":"10.1097\/MD.0000000000004874","volume":"95","author":"SH Lee","year":"2016","unstructured":"Lee SH, Kim YS, Han W et al. (2016) Tumor growth rate of invasive breast cancers during wait times for surgery assessed by ultrasonography [published online September 16, 2016]. Medicine (Baltimore) 95(37):e4874. https:\/\/doi.org\/10.1097\/MD.0000000000004874","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"946_CR61","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12282-018-0914-0","volume":"26","author":"K Nakashima","year":"2019","unstructured":"Nakashima K, Uematsu T, Takahashi K et al. (2019) Does breast cancer growth rate really depend on tumor subtype? Measurement of tumor doubling time using serial ultrasonography between diagnosis and surgery. Breast Cancer 26(2):206\u2013214. https:\/\/doi.org\/10.1007\/s12282-018-0914-0","journal-title":"Breast Cancer"},{"issue":"2","key":"946_CR62","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24877","volume":"81","author":"H Kaufmann","year":"2017","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Autonomic Disorders Consortium et al. (2017) Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol 81(2):287\u2013297. https:\/\/doi.org\/10.1002\/ana.24877","journal-title":"Ann Neurol"},{"issue":"3","key":"946_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10286-020-00682-5","volume":"30","author":"C Xia","year":"2020","unstructured":"Xia C, Postuma RB (2020) Diagnosing multiple system atrophy at the prodromal stage. Clin Auton Res 30(3):197\u2013205. https:\/\/doi.org\/10.1007\/s10286-020-00682-5","journal-title":"Clin Auton Res"},{"issue":"2","key":"946_CR64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10286-017-0500-0","volume":"28","author":"JH McKay","year":"2018","unstructured":"McKay JH, Cheshire WP (2018) First symptoms in multiple system atrophy. Clin Auton Res 28(2):215\u2013221. https:\/\/doi.org\/10.1007\/s10286-017-0500-0","journal-title":"Clin Auton Res"},{"key":"946_CR65","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8724-21","author":"R Sakakibara","year":"2022","unstructured":"Sakakibara R, Sekiguchi Y, Panicker NJ et al. (2022) Female urinary retention progressing to possible multiple system atrophy-cerebellar form after 12 years. Intern Med. https:\/\/doi.org\/10.2169\/internalmedicine.8724-21","journal-title":"Intern Med"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-023-00946-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-023-00946-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-023-00946-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T09:05:48Z","timestamp":1692349548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-023-00946-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1007\/s10286-023-00946-w","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}